Comerica Bank
IMVT icon

Comerica Bank’s Immunovant IMVT Stock Holding History

Comerica Bank’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$8.11K Hold
319
– – ﹤0.01% 3290
2025
Q3 		$5.14K Buy
319
+38
+14% +$615 ﹤0.01% 3394
2025
Q2 		$4.5K Buy
+281
New +$4.25K ﹤0.01% 3380
2025
Q1 		– Sell
-96
Closed -$2.38K – 3729
2024
Q4 		$2.38K Sell
96
-4
-4% -$113 ﹤0.01% 3456
2024
Q3 		$2.85K Sell
100
-483
-83% -$14.2K ﹤0.01% 3434
2024
Q2 		$15.4K Buy
583
+59
+11% +$1.68K ﹤0.01% 3062
2024
Q1 		$16.9K Sell
524
-146
-22% -$5.33K ﹤0.01% 3076
2023
Q4 		$28.2K Sell
670
-11
-2% -$405 ﹤0.01% 2882
2023
Q3 		$26.1K Buy
+681
New +$15.4K ﹤0.01% 2917

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Comerica Bank's IMVT Position: Q4 2025 in Review

Comerica Bank held its Immunovant (IMVT) position steady in Q4 2025 at 319 shares worth $8.11K. The position accounts for ﹤0.01% of the portfolio, ranked #3290.

Comerica Bank first reported a position in IMVT in Q3 2023 and has held it in 9 quarters since. The position peaked at $28.2K in Q4 2023. 196 funds tracked by Wall St. Rank hold IMVT as of Q4 2025.

  • Comerica Bank held 319 shares of Immunovant worth $8.11K as of Q4 2025.
  • Comerica Bank left its Immunovant share count unchanged in Q4 2025.
  • Immunovant made up ﹤0.01% of Comerica Bank's portfolio in Q4 2025, its #3290 holding.
  • Comerica Bank first reported a position in Immunovant in Q3 2023 and has held it in 9 quarters since.
  • Comerica Bank's Immunovant position peaked at $28.2K in Q4 2023.
  • 196 funds tracked by Wall St. Rank held Immunovant as of Q4 2025.

Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.